1. Home
  2. COST vs AMGN Comparison

COST vs AMGN Comparison

Compare COST & AMGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Costco Wholesale Corporation

COST

Costco Wholesale Corporation

N/A

Current Price

$1,003.54

Market Cap

449.2B

ML Signal

N/A

Logo Amgen Inc.

AMGN

Amgen Inc.

N/A

Current Price

$368.25

Market Cap

202.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COST
AMGN
Founded
1976
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
449.2B
202.4B
IPO Year
1994
2000

Fundamental Metrics

Financial Performance
Metric
COST
AMGN
Price
$1,003.54
$368.25
Analyst Decision
Buy
Hold
Analyst Count
21
19
Target Price
$1,073.15
$345.39
AVG Volume (30 Days)
1.7M
2.2M
Earning Date
06-04-2026
05-05-2026
Dividend Yield
0.52%
2.67%
EPS Growth
9.96
88.23
EPS
9.08
14.23
Revenue
$275,235,000,000.00
$25,424,000,000.00
Revenue This Year
$10.12
$4.98
Revenue Next Year
$7.44
$2.49
P/E Ratio
$220.55
$26.56
Revenue Growth
8.17
8.83
52 Week Low
$844.06
$265.66
52 Week High
$1,067.08
$391.29

Technical Indicators

Market Signals
Indicator
COST
AMGN
Relative Strength Index (RSI) 56.41 49.43
Support Level $1,002.00 $361.40
Resistance Level $1,024.63 $388.21
Average True Range (ATR) 17.91 8.73
MACD -2.15 -2.28
Stochastic Oscillator 72.51 26.41

Price Performance

Historical Comparison
COST
AMGN

About COST Costco Wholesale Corporation

Founded in 1983, Costco Wholesale now operates a global chain of membership-based warehouse clubs, delivering high-quality goods and services at consistently low prices. As of its most recent fiscal year, Costco operated approximately 910 warehouses, serving more than 80 million members across its three geographic segments: Costco US (approximately 73% of total revenue), Costco Canada (13%), and Costco International (14%).Costco's core value proposition—quality products at unbeatable prices—has yielded consistently strong member renewal rates (93% in the US and Canada and nearly 90% internationally). About 55% of Costco's fiscal 2025 revenue came from its grocery offerings, and another 25% from general merchandise.

About AMGN Amgen Inc.

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Share on Social Networks: